Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1

Area of Science:

• Molecular Biology
• Genetics
• Neuromuscular Disorders

Background:

• Myotonic dystrophy type 1 (DM1) is a genetic disorder caused by CTG-repeat expansions.
• DM1 presents a multisystemic phenotype, primarily affecting muscles and the brain.
• While alternative splicing defects are known, other contributing factors to DM1 pathogenesis remain unclear.

Purpose of the Study:

• To investigate additional molecular factors contributing to DM1 pathology.
• To analyze gene expression and splicing alterations in DM1 myoblasts and myotubes.
• To identify potential therapeutic targets beyond mature muscle cells.

Main Methods:

• RNA sequencing (RNAseq) and gene expression analysis were performed on primary human myoblasts and differentiated myotubes.
• Gene Ontology (GO) term analysis was used to identify molecular pathologies.
• Gene set enrichment analysis focused on splicing to identify misregulated complexes.

Main Results:

• GO-term analysis revealed distinct molecular pathologies in DM1 myoblasts and myotubes contributing to the muscular phenotype.
• Gene set enrichment identified misregulated, differentiation stage-specific splicing complexes in DM1.
• These findings highlight the complexity of the alternative splicing phenotype in DM1.

Conclusions:

• The study adds complexity to the understanding of alternative splicing defects in DM1.
• Therapeutic strategies for DM1 may need to target both mature muscle cells and satellite cells (muscle stem cells).
• Identifying misregulated splicing complexes offers potential avenues for novel therapeutic interventions.